Evommune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evommune and other ETFs, options, and stocks.About EVMN
Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases.
CEOLuis C. Peña
CEOLuis C. Peña
Employees41
Employees41
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2020
Founded2020
Employees41
Employees41
EVMN Key Statistics
Market cap543.63M
Market cap543.63M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume141.24K
Average volume141.24K
High today$20.85
High today$20.85
Low today$17.20
Low today$17.20
Open price$20.85
Open price$20.85
Volume116.30K
Volume116.30K
52 Week high$24.03
52 Week high$24.03
52 Week low$16.00
52 Week low$16.00
Stock Snapshot
The current Evommune(EVMN) stock price is $18.00, with a market capitalization of 543.63M.
During the trading session on 2025-12-13, Evommune(EVMN) shares reached a daily high of $20.85 and a low of $17.20. At a current price of $18.00, the stock is +4.6% higher than the low and still -13.7% under the high.
Trading volume for Evommune(EVMN) stock has reached 116.3K, versus its average volume of 141.24K.
Over the past 52 weeks, Evommune(EVMN) stock has traded between a high of $24.03 and a low of $16.00.
Over the past 52 weeks, Evommune(EVMN) stock has traded between a high of $24.03 and a low of $16.00.
People also own
Based on the portfolios of people who own EVMN. This list is generated using Robinhood data, and it’s not a recommendation.